Shenandoah Therapeutics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $21.5M

  • Investors
  • 5

Shenandoah Therapeutics General Information

Description

Developer of an oncology technology platform designed for cancer treatment. The company's platform utilizes a combination of proteins, including transcriptional chemical inducers of proximity, which trigger cancer cells to self-destruct, enabling medical professionals to offer new therapeutic options for cancer patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 329 Oyster Point Boulevard
  • 3rd Floor
  • South San Francisco, CA 94080
  • United States
+1 (650)
Primary Industry
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • 329 Oyster Point Boulevard
  • 3rd Floor
  • South San Francisco, CA 94080
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Shenandoah Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 31-Mar-2025 $21.5M Completed Stealth
To view Shenandoah Therapeutics’s complete valuation and funding history, request access »

Shenandoah Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-2
Seed-1
To view Shenandoah Therapeutics’s complete cap table history, request access »

Shenandoah Therapeutics Patents

Shenandoah Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026148150-A1 Compositions and methods for treating autoimmune diseases Pending 31-Dec-2024

Shenandoah Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Shenandoah Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
First Spark Ventures Venture Capital Minority
Honghui Capital Venture Capital Minority
Samsara BioCapital Venture Capital Minority
Time BioVentures Venture Capital Minority
YK Bioventures Venture Capital Minority
To view Shenandoah Therapeutics’s complete investors history, request access »

Shenandoah Therapeutics FAQs

  • When was Shenandoah Therapeutics founded?

    Shenandoah Therapeutics was founded in 2022.

  • Where is Shenandoah Therapeutics headquartered?

    Shenandoah Therapeutics is headquartered in South San Francisco, CA.

  • What is the size of Shenandoah Therapeutics?

    Shenandoah Therapeutics has 5 total employees.

  • What industry is Shenandoah Therapeutics in?

    Shenandoah Therapeutics’s primary industry is Discovery Tools (Healthcare).

  • Is Shenandoah Therapeutics a private or public company?

    Shenandoah Therapeutics is a Private company.

  • What is the current valuation of Shenandoah Therapeutics?

    The current valuation of Shenandoah Therapeutics is .

  • What is Shenandoah Therapeutics’s current revenue?

    The current revenue for Shenandoah Therapeutics is .

  • How much funding has Shenandoah Therapeutics raised over time?

    Shenandoah Therapeutics has raised $21.5M.

  • Who are Shenandoah Therapeutics’s investors?

    First Spark Ventures, Honghui Capital, Samsara BioCapital, Time BioVentures, and YK Bioventures have invested in Shenandoah Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process